Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
Conditions: Malignant Mesothelioma; Colorectal Cancer; Bile Duct Cancer; Rectal Cancer; Ovary Cancer; Pancreatic Cancer; Breast Cancer Female Interventions: Biological: UCMYM802 Injection Sponsors: UTC Therapeutics Inc.; Peking University Cancer Hospital& Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Bile | Bile Duct Cancer | Breast Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Colorectal Cancer | Hospitals | Mesothelioma | Ovaries | Pancreas | Pancreatic Cancer | Rectal Cancers | Research | Study